Literature DB >> 36094546

Partially hydrolyzed guar gum alleviates hepatic steatosis and alters specific gut microbiota in a murine liver injury model.

Takayuki Fujii1, Haruyuki Nakayama-Imaohji2, Aya Tanaka3, Hiroto Katami3, Kazuya Tanaka3, Yoichi Chiba4, Machi Kawauchi4, Masaki Ueno4, Tomomi Kuwahara2, Ryuichi Shimono3.   

Abstract

PURPOSE: The gut microbiota, via the gut-liver axis, plays an important role in the development of intestinal failure-associated liver disease. Here, we investigated whether partially hydrolyzed guar gum (PHGG), a dietary fiber could alleviate liver damage and modulate the gut microbiota in a murine liver injury (LI) model.
METHODS: Liver injury was induced in 6-week-old male C57BL/6 mice using an enteral liquid diet composed of parenteral nutrition (LI group) and treated with 5% PHGG (LI/PHGG group). Liver histopathology was examined using oil red O and a tumor necrosis factor-α (TNF-α) labeling. The gut microbiota was examined using 16S rRNA gene sequencing.
RESULTS: Lipid accumulation was significantly decreased in the LI /PHGG group when compared with that of the LI group. The area of TNF-α-positive cells was significantly higher in the LI group when compared with that of the control. The principal coordinate analysis (PCoA) revealed pronounced changes in the gut microbiota after PHGG treatment. Linear discriminant analysis of effect size showed that PHGG treatment significantly increased cecal abundance of Parabacteroides.
CONCLUSIONS: PHGG alleviated hepatic steatosis following liver injury in mice. The protective effect of PHGG treatment could be associated with increased abundance of Parabacteroides in the cecum.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Cholestasis; Dietary fiber; Intestinal failure; PNALD; Short bowel syndrome; Steatosis

Year:  2022        PMID: 36094546     DOI: 10.1007/s00383-022-05221-z

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   2.003


  37 in total

1.  Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease.

Authors:  R D Christensen; E Henry; S E Wiedmeier; J Burnett; D K Lambert
Journal:  J Perinatol       Date:  2007-03-08       Impact factor: 2.521

2.  Alterations in intestinal microbiota relate to intestinal failure-associated liver disease and central line infections.

Authors:  Panliang Wang; Ying Wang; Lina Lu; Weihui Yan; Yijing Tao; Kejun Zhou; Jie Jia; Wei Cai
Journal:  J Pediatr Surg       Date:  2017-05-03       Impact factor: 2.545

3.  Partially hydrolysed guar gum ameliorates murine intestinal inflammation in association with modulating luminal microbiota and SCFA.

Authors:  Tomohisa Takagi; Yuji Naito; Yasuki Higashimura; Chihiro Ushiroda; Katsura Mizushima; Yuji Ohashi; Zenta Yasukawa; Makoto Ozeki; Makoto Tokunaga; Tsutomu Okubo; Kazuhiro Katada; Kazuhiro Kamada; Kazuhiko Uchiyama; Osamu Handa; Yoshito Itoh; Toshikazu Yoshikawa
Journal:  Br J Nutr       Date:  2016-09-08       Impact factor: 3.718

4.  Intestinal failure-associated liver disease in hospitalised children.

Authors:  Judith Pichler; Venetia Horn; Sarah Macdonald; Susan Hill
Journal:  Arch Dis Child       Date:  2012-01-13       Impact factor: 3.791

5.  Alterations of gut microbiota and serum bile acids are associated with parenteral nutrition-associated liver disease.

Authors:  Nan Wang; Jiazheng Wang; Tian Zhang; Liufang Huang; Weihui Yan; Lina Lu; Jie Jia; Yijing Tao; Wei Cai; Ying Wang
Journal:  J Pediatr Surg       Date:  2020-06-27       Impact factor: 2.545

6.  The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection.

Authors:  Nanda Burger-van Paassen; Audrey Vincent; Patrycja J Puiman; Maria van der Sluis; Janneke Bouma; Günther Boehm; Johannes B van Goudoever; Isabelle van Seuningen; Ingrid B Renes
Journal:  Biochem J       Date:  2009-05-13       Impact factor: 3.857

7.  A sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion.

Authors:  George M H Birchenough; Elisabeth E L Nyström; Malin E V Johansson; Gunnar C Hansson
Journal:  Science       Date:  2016-06-24       Impact factor: 47.728

Review 8.  Interactions between the microbiota and the immune system.

Authors:  Lora V Hooper; Dan R Littman; Andrew J Macpherson
Journal:  Science       Date:  2012-06-06       Impact factor: 47.728

9.  ESPEN practical guideline: Clinical nutrition in chronic intestinal failure.

Authors:  Cristina Cuerda; Loris Pironi; Jann Arends; Federico Bozzetti; Lyn Gillanders; Palle Bekker Jeppesen; Francisca Joly; Darlene Kelly; Simon Lal; Michael Staun; Kinga Szczepanek; André Van Gossum; Geert Wanten; Stéphane Michel Schneider; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2021-08-02       Impact factor: 7.324

Review 10.  Impact of Parenteral Lipid Emulsion Components on Cholestatic Liver Disease in Neonates.

Authors:  Gregory Guthrie; Douglas Burrin
Journal:  Nutrients       Date:  2021-02-04       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.